Quantcast
Last updated on April 16, 2014 at 13:48 EDT

Latest Hae Stories

2014-04-01 16:25:42

BRAINTREE, Mass., April 1, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) will announce its earnings for the fourth quarter and full fiscal year 2014 and will provide guidance for fiscal year 2015( )on April 28, 2014 in a pre-market press release. The Company will hold a webcast to discuss and answer questions about the press release at 8:00 am (EDT) on April 28, 2014. Webcast Link:...

2014-03-24 08:28:19

BRAINTREE, Mass., March 24, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that it was not selected to supply The American Red Cross with certain whole blood collection components. The Company was informed that a competitor was chosen to supply these products on an exclusive basis. Haemonetics provided the following information regarding its whole blood collection kit business with The American Red Cross: -- Haemonetics currently supplies 1.8 million in-line...

2014-03-01 12:20:36

Analysis also reveals decrease in emergency room visits and hospitalizations SAN DIEGO, March 1, 2014 /PRNewswire/ -- Findings announced by CSL Behring today show that current hereditary angioedema (HAE) treatment options, such as C1 Esterase Inhibitor (C1-INH) concentrate, are allowing for greater patient satisfaction, higher rates of home treatment and a decrease in the number of hospitalizations and visits to the emergency room. HAE is a rare, potentially fatal swelling disorder...

2014-02-20 08:32:25

International study by CSL Behring is world's first placebo-controlled phase III trial to examine subcutaneous administration of C1-INH for use in treating rare, sometimes life-threatening, condition KING OF PRUSSIA, Pa., Feb. 20, 2014 /PRNewswire/ -- CSL Behring today announced it has enrolled the first patient in COMPACT, an international phase III study of a volume-reduced, subcutaneous formulation of C1-esterase inhibitor (C1-INH) concentrate in patients with frequent hereditary...

2014-02-13 08:30:47

BRAINTREE, Mass., Feb. 13, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at the Raymond James 35(th) Annual Institutional Investors Conference in Orlando, FL on Tuesday, March 4, 2014 at 8:05 am Eastern time. The public may access Mr. Concannon's presentation live via webcast at http://wsw.com/webcast/rj89/HAE The webcast will be archived and available for approximately 90 days. Haemonetics (NYSE:...

2014-02-05 08:29:30

BRAINTREE, Mass., Feb. 5, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that it will host its annual investor and analyst meeting on Tuesday, May 20(th) from 10:00 am to 2:00 pm at The State Room, 60 State Street in Boston, Massachusetts. (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The agenda for the meeting includes updates on the following: -- Whole Blood Strategy / U.S. Tenders / International Expansion Plans -- Hospital Based...

2014-01-12 16:20:26

BRAINTREE, Mass., Jan. 12, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that it has entered into a multi-year agreement to supply the HemeXcel Purchasing Alliance LLC with certain whole blood collection components on an exclusive basis during calendar years 2014-2016. The announcement was made in conjunction with the 32(nd) Annual J.P. Morgan Health Care Conference in San Francisco. (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) "We...

2014-01-03 16:22:34

BRAINTREE, Mass., Jan. 3, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that it will provide a general business update, including an update with respect to ongoing U.S. whole blood tenders, in conjunction with the 32nd Annual J.P. Morgan Health Care Conference in San Francisco. Brian Concannon, President and CEO of Haemonetics, will comment on these tenders as part of a live webcast presentation at 10:00AM Pacific / 1:00PM Eastern time on Wednesday, January...

2014-01-02 16:22:21

BRAINTREE, Mass., Jan. 2, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at the 32(nd) Annual J.P. Morgan Health Care Conference in San Francisco on Wednesday, January 15, 2014 at 10:00 am Pacific time / 1:00 pm Eastern time. (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The public may access Mr. Concannon's presentation live via webcast at...

2013-12-20 16:24:34

BRAINTREE, Mass., Dec. 20, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) will announce its earnings for the third quarter of its fiscal year 2014 on January 27, 2014 in a pre-market press release. The company will host a conference call which will be webcast, to discuss and answer questions about the press release at 8:00 am Eastern on January 27, 2014. (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO) Webcast Link:...